首页> 外文会议>Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXIII >Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers
【24h】

Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers

机译:图像导向的靶向双光子PDT的开发,用于治疗头颈癌

获取原文
获取原文并翻译 | 示例

摘要

There has been significant effort over the past two decades in the treatment of malignancies of epithelial origin, including some of the most devastating of cancers, such as colorectal cancer (CRC), squamous call carcinoma of the head and neck (HNSCC), and carcinomas of the pancreas, lungs, (both Small Cell and Non-Small Cell), renal cell, prostate, bladder and breast. Recurring, refractory HNSCC is a particularly difficult cancer to treat once the tumors recur due to mutations that are resistant to repeat chemotherapy and radiation. In addition, repeat surgery is often difficult due to the requirement of significant surgical margins that may not be possible due to the attending potential functional deficits (e.g., salivary glands, nerves and major blood vessels in confined areas). In this study FaDu HNSCC xenograft tumors in SCID mice were imaged, and "optical", as opposed to "surgical" margins defined for the tumor being treated. The subsequent two-photon treatment irradiation was computer-controlled to carry out the tumor treatment by rastering the laser beam throughout the tumor volume plus the defined optical margins simultaneously. In our initial studies, up to 85% regression in tumor volume was observed in 5 days post PDT, with complete tumor regression in 18 days. No re-growth was observed up to 41 days post-PDT, with little or no scarring and complete hair re-growth. However, competition between imaging and PDT moieties was also observed in some mouse models, possibly favoring tumor re-growth. Strategies to selectively optimize the PDT effect will be discussed.
机译:在过去的二十年中,人们在治疗上皮性恶性肿瘤方面做出了巨大的努力,其中包括一些最具破坏性的癌症,例如结直肠癌(CRC),头颈部鳞状上皮癌(HNSCC)和癌胰腺,肺(小细胞和非小细胞),肾细胞,前列腺,膀胱和乳房。复发的难治性HNSCC癌一旦因对重复化疗和放疗有抵抗力的突变而复发,则是很难治疗的癌症。此外,由于需要大量的手术余量,因此重复手术通常很困难,而由于存在潜在的功能缺陷(例如,狭窄区域的唾液腺,神经和主要血管),这可能是不可能的。在这项研究中,对SCID小鼠中的FaDu HNSCC异种移植肿瘤进行了成像,并显示了“光学”,而不是为要治疗的肿瘤定义的“手术”切缘。随后的两光子治疗照射是计算机控制的,通过同时光栅化整个肿瘤体积内的激光束以及定义的光学范围来进行肿瘤治疗。在我们的初步研究中,PDT后5天内观察到肿瘤体积消退高达85%,而18天内肿瘤完全消退。在PDT后直至41天,未观察到重新生长,几乎没有或没有疤痕,并且完全重新生长了头发。但是,在某些小鼠模型中还观察到成像和PDT部分之间的竞争,这可能有利于肿瘤的重新生长。将讨论选择性优化PDT效果的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号